The Ensign Group, Inc. $ENSG Stock Position Trimmed by Crow s Nest Holdings LP

Crow s Nest Holdings LP cut its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 1.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 432,100 shares of the company’s stock after selling 7,900 shares during the quarter. The Ensign Group comprises approximately 15.6% of Crow s Nest Holdings LP’s holdings, making the stock its 2nd largest holding. Crow s Nest Holdings LP owned approximately 0.75% of The Ensign Group worth $74,654,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. raised its stake in shares of The Ensign Group by 20.2% in the third quarter. JPMorgan Chase & Co. now owns 433,600 shares of the company’s stock valued at $74,913,000 after acquiring an additional 72,923 shares during the period. State of New Jersey Common Pension Fund D grew its holdings in The Ensign Group by 10.8% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 18,862 shares of the company’s stock valued at $3,259,000 after purchasing an additional 1,839 shares during the last quarter. Hardy Reed LLC purchased a new stake in The Ensign Group in the 3rd quarter worth about $220,000. PNC Financial Services Group Inc. lifted its stake in The Ensign Group by 10.0% in the third quarter. PNC Financial Services Group Inc. now owns 3,596 shares of the company’s stock worth $621,000 after purchasing an additional 328 shares during the last quarter. Finally, Assetmark Inc. boosted its position in shares of The Ensign Group by 115.5% during the third quarter. Assetmark Inc. now owns 888 shares of the company’s stock valued at $153,000 after buying an additional 476 shares during the period. Institutional investors own 96.12% of the company’s stock.

Insider Activity at The Ensign Group

In related news, VP Beverly B. Wittekind sold 2,000 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $180.00, for a total transaction of $360,000.00. Following the sale, the vice president owned 32,779 shares of the company’s stock, valued at $5,900,220. This trade represents a 5.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director John O. Agwunobi sold 146 shares of the business’s stock in a transaction dated Wednesday, January 21st. The stock was sold at an average price of $178.31, for a total transaction of $26,033.26. Following the completion of the transaction, the director owned 9,087 shares of the company’s stock, valued at $1,620,302.97. This represents a 1.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 29,032 shares of company stock valued at $5,373,698 over the last 90 days. Insiders own 3.90% of the company’s stock.

The Ensign Group Stock Performance

Shares of The Ensign Group stock opened at $213.34 on Monday. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.06. The stock’s fifty day moving average price is $180.23 and its 200-day moving average price is $176.35. The firm has a market cap of $12.36 billion, a P/E ratio of 36.53, a P/E/G ratio of 2.23 and a beta of 0.88. The Ensign Group, Inc. has a 12 month low of $118.73 and a 12 month high of $216.92.

The Ensign Group (NASDAQ:ENSG) last issued its earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.07. The company had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. The Ensign Group had a net margin of 6.80% and a return on equity of 16.76%. The firm’s quarterly revenue was up 20.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.49 EPS. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. On average, equities research analysts expect that The Ensign Group, Inc. will post 5.59 earnings per share for the current fiscal year.

The Ensign Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, January 31st. Investors of record on Wednesday, December 31st were paid a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. This is a positive change from The Ensign Group’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend was Wednesday, December 31st. The Ensign Group’s payout ratio is presently 4.45%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Royal Bank Of Canada reiterated an “outperform” rating and issued a $222.00 price target (up from $206.00) on shares of The Ensign Group in a report on Monday, February 9th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of The Ensign Group in a research report on Thursday, January 22nd. Truist Financial set a $215.00 target price on The Ensign Group and gave the stock a “hold” rating in a research note on Friday, February 6th. Stephens boosted their target price on shares of The Ensign Group from $185.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Finally, UBS Group set a $230.00 price target on shares of The Ensign Group and gave the stock a “buy” rating in a report on Friday, February 6th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $204.60.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.